Cavanaugh Stefanie L. 4
4 · Aspira Women's Health Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
Cavanaugh Stefanie L.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-12-31+5,937→ 66,851 total - Exercise/Conversion
Restricted Stock Units
2024-12-31−5,937→ 11,875 total→ Common Stock (5,937 underlying)
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
- [F3]On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.